Latest News and Press Releases

SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTC: NBIO) Announced today that its Senior Officers have converted the Company’s liability to them into common stock, reducing the...

SAN DIEGO, June 24, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTC: NBIO) announced today that it has appointed Dr. Navpaul Singh MD as Chief Medical Consultant in charge of research into...

SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTCQB: NBIO), today announced after receiving early In-Vitro study results Pritumumab, (PTB), will be advanced to laboratory-based...

SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO) (the “Company” or “Nascent”) is pleased to announce that the Company will soon  begin Phase 1 clinical trials for a...

SAN DIEGO, May 12, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat cancers and viral...

SAN DIEGO, May 06, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO). On April 22, 2020, Nascent Biotech Inc. (the “Company”) notified Triton Funds, LLC (“Triton”) that it was...

SAN DIEGO, April 22, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc., (OTCQB: NBIO) (the “Company” or “Nascent”) a leading biotechnology company developing proprietary human Monoclonal Antibodies...

SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) -- Nascent, Biotech, Inc., (OTCQB: NBIO), a biotechnology company developing proprietary human Monoclonal Antibodies (mAbs) and immunotherapy for treatment...